Featured Research

First Mouse Model For Multiple System Atrophy Points To New Treatment Targets For Brain Diseases

Date:

April 1, 2005

Source:

University Of Pennsylvania Medical Center

Summary:

A newly developed animal model for Multiple System Atrophy (MSA) - a collection of neurodegenerative disorders once thought to be three separate diseases - sheds new light on this little-studied brain disease, according to research from investigators at the University of Pennsylvania School of Medicine.

Share This

Philadelphia, PA - A newly developed animal model for Multiple System Atrophy (MSA) - a collection of neurodegenerative disorders once thought to be three separate diseases - sheds new light on this little-studied brain disease, according to research from investigators at the University of Pennsylvania School of Medicine.

Related Articles

Virginia M.-Y. Lee, PhD, Director of Penn’s Center for Neurodegenerative Disease Research, and colleagues demonstrated that the mice showed symptoms similar to human MSA. These include an accumulation of a protein called a-synuclein in oligodendrocytes - cells that produce the protective myelin sheath that covers axons. This protein accumulation disables oligodendrocytes, leading to a loss of the sheath on neurons and eventually nerve-cell malfunction and death. The mice also showed slowly progressive problems with their motor skills associated with the nerve-cell damage. Neurons are important in transmitting signals and in maintaining learning and memory.

“The uniqueness of this disease is that, unlike most of the neurodegenerative diseases, which affect neurons primarily and oligodendrocytes secondarily, this is the other way around,” says Lee. In fact, there is growing evidence that non-neuronal cells also play a role in amyloid deposits in Alzheimer’s disease and amyotrophic lateral sclerosis (ALS) mouse models. Lee and colleagues report their findings in the March 24, 2005 issue of Neuron.

MSA is so named because it affects multiple parts of the nervous system. Initially MSA was given three names, based on the symptoms physicians had observed. However, when they closely examined patients’ pathology, the disorders seemed related, based on the a-synuclein proteins in cells. In the clinic, many patients with MSA present with symptoms similar to Parkinson’s disease (PD), and MSA has been misdiagnosed as such.

Collectively, MSA now includes three related disorders characterized by their most prominent symptoms: olivopontocerebellar atrophy, which affects balance, coordination, and speech; striatonigral degeneration, the closest to Parkinson’s disease because of slow movement and stiff muscles; and Shy-Drager syndrome, which involves altered bowel, bladder, and blood-pressure control. Other general symptoms include dizziness, impaired speech, breathing and swallowing difficulties, and blurred vision. Most patients develop dementia late in the course of the disease, which is usually diagnosed in people over 50.

Currently there is no specific drug to treat the myelin and nerve damage caused by the protein inclusions. Parkinson’s disease drugs and others are used to alleviate early symptoms. “With this animal model, we now can plan tests of potential therapies for Multiple System Atrophy as part of our drug discovery program for Parkinson’s disease, MSA, and related disorders,” says Lee.

The study was funded in part by the National Institutes of Health. Ikuru Yazawa, Benoit I. Giasson, Ryogen Sasaki, Bin Zhang, Sonali Joyce, Kunihuro Uryu, and John Q. Trojanowski, all from Penn, are study co-authors. The authors report no conflicts of interests related to this research.

University Of Pennsylvania Medical Center. "First Mouse Model For Multiple System Atrophy Points To New Treatment Targets For Brain Diseases." ScienceDaily. ScienceDaily, 1 April 2005. <www.sciencedaily.com/releases/2005/03/050329131521.htm>.

University Of Pennsylvania Medical Center. (2005, April 1). First Mouse Model For Multiple System Atrophy Points To New Treatment Targets For Brain Diseases. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/2005/03/050329131521.htm

University Of Pennsylvania Medical Center. "First Mouse Model For Multiple System Atrophy Points To New Treatment Targets For Brain Diseases." ScienceDaily. www.sciencedaily.com/releases/2005/03/050329131521.htm (accessed March 31, 2015).

Featured Research

Mar. 31, 2015  Researchers have illuminated an important distinction between mice and humans: how human livers heal. The difference centers on a protein called PPAR alpha which activates liver ... full story

Mar. 31, 2015  Researchers have recorded the first direct observations of the micro-scale mechanisms behind the ability of skin to resist tearing. The results could be applied to the improvement of artificial skin, ... full story

Mar. 31, 2015  Fewer than half of the physicians trained in the United States in 2013 received formal education or training on the subject of exercise, according to new research. "There are immense medical benefits ... full story

Mar. 31, 2015  Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer's given an experimental cancer drug, researchers report. "With this treatment, cells under ... full story

Mar. 31, 2015  Increasing state alcohol taxes could prevent thousands of deaths a year from car crashes, say researchers, who found alcohol-related motor vehicle crashes decreased after taxes on beer, wine and ... full story

Mar. 31, 2015  Alcoholism takes a toll on every aspect of a person's life, including skin problems. Now, a new research report helps explain why this happens and what might be done to address it. "The clinical ... full story

Mar. 31, 2015  A new population of 'memory' immune cells has been discovered by scientists, throwing light on what the body does when it sees a microbe for the second time. This insight, and others like it, will ... full story

Mar. 31, 2015  Coronary heart disease and stroke, two of the leading causes of death in the United States, are diseases associated with heightened platelet reactivity. A new study in humans suggests an underlying ... full story

Mar. 31, 2015  A new study had researchers seeking answers to why the therapeutic benefit afforded by SSRIs was so limited in children and teenagers. If researchers can uncover the biological mechanisms preventing ... full story

Featured Videos

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015)  The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports.
Video provided by Reuters

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015)  Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline.
Video provided by Washington Post

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015)  Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17
Video provided by AFP

Related Stories

Dec. 2, 2014  A rogue protein has been identified in multiple sclerosis, which attacks the body's central nervous system. Reporting for the first time, researchers believe this finding could pave the way for ... full story

June 10, 2013  Low baseline diastolic blood pressure (DBP) appears to be associated with brain atrophy in patients with arterial disease, whenever declining levels of blood pressure (BP) over time among patients ... full story

Apr. 18, 2013  An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people who are at risk for schizophrenia. The findings suggest a potential diagnostic tool for identifying ... full story

Dec. 12, 2011  Atrophy in the hippocampus, the region of the brain known for memory formation and storage, is evident in Parkinson's disease patients with cognitive impairment, including early decline known as ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.